6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
8m ago	ATEX Releases 2025 Sustainability Report
8m ago	Manulife Financial Corporation announces Dividend Rates on Non-cumulative Rate Reset Class 1 Shares Series 3 and Non-cumulative Floating Rate Class 1 Shares Series 4
9m ago	Genco Shipping & Trading Limited Files Investor Presentation and Urges Shareholders to Vote for the Company’s Highly Qualified Nominees and Reject Diana’s Inadequate Tender Offer
9m ago	Americold Realty Trust, Inc. Declares Second Quarter 2026 Dividend
9m ago	Nike : Debuts Sportswear Collections Inspired by the Emotion, Energy and Expression of Football

About

61.94USD+2.38 +4.00%

Closed • Updated at 20:56 GMT+00:00

Market Cap$2.88B

P/E Ratio30.49

Volume1.18M

Beta0.16

RSI61.13

Gross Margin55.70%

Health TechnologyMedical Specialties

Haemonetics Corporation — investor relations, events, news, and company updates on 6ix.

Latest News

Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Haemonetics to Present at Bank of America 2026 Healthcare Conference

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

Community Chat

Ask AI